Placebo News and Research

RSS

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.

23 Nov 2020

Sinovac Biotech's COVID-19 vaccine candidate triggers immune response

Now, Sinovac Biotech's candidate vaccine, CoronaVac, has been found to induce an immune response in healthy adults aged 18–59 years, 28 days post-vaccination. However, the level of antibodies generated was lower than in people who had recovered from the illness.

19 Nov 2020

Texas Heart Institute to participate in a study to treat ARDS in hospitalized COVID-19 patients

Texas Heart Institute has been selected as one of up to 60 sites in the world to participate in an international investigative study seeking to aid COVID-19 patients who develop acute respiratory distress syndrome (ARDS).

19 Nov 2020

NIH-funded study to test emergency treatment for devastating stroke in Memphis

The University of Tennessee Health Science Center's Stroke Team is joining researchers from more than 100 hospitals worldwide to conduct a National Institutes of Health (NIH)-funded research study called FASTEST that will test the safety and efficacy of a medication called recombinant factor Vlla to prevent hemorrhage expansion in patients with strokes caused by bleeding in the brain - intracerebral hemorrhage strokes.

19 Nov 2020

Blood pressure drug eases recovery for alcoholics with withdrawal symptoms

A drug once used to treat high blood pressure can help alcoholics with withdrawal symptoms reduce or eliminate their drinking, Yale University researchers report Nov. 19 in the American Journal of Psychiatry.

19 Nov 2020

UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients

The University of Illinois Chicago will conduct three clinical trials for studying blood clot prevention in patients with COVID-19.

18 Nov 2020

Vitamin D3 supplementation shows no therapeutic benefits in severe COVID-19 patients, study finds

A team of researchers at the University of São Paulo in Brazil aimed to determine if vitamin D3 supplementation reduces the length of stay in hospitalized patients with severe COVID-19.

18 Nov 2020

Investigational drug helped improve heart health in patients with chronic conditions

The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Combination of ticagrelor and aspirin reduces subsequent stroke risk in patients with heart plaque

Patients with plaque build-up in their arteries, who suffered a transient ischemic attack (TIA) or a minor ischemic stroke, also called a warning stroke, and were treated with the newer blood thinner ticagrelor plus aspirin were 27% less likely to have another stroke within 30 days, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

A novel diabetes medication significantly reduces the risk of hospitalization for heart failure, heart attack and stroke, in patients with Type 2 diabetes and chronic kidney disease, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Study: Novel drug may treat reproductive health problems in women

A drug that acts via the natural 'kisspeptin' hormone system in the body has the potential to treat reproductive health problems in women, according to a new study.

17 Nov 2020

Researchers report encouraging results from in vitro combination therapy against COVID-19

Researchers at Karolinska Institutet in Sweden report promising results from an in vitro combination therapy against COVID-19.

17 Nov 2020

Study shows favorable impact of medication on cardiac structure and function

For the first time, medication has impacted heart muscle thickness and function for patients with the most common inherited heart condition, rather than simply addressing their symptoms.

17 Nov 2020

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance.

17 Nov 2020

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.

16 Nov 2020

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Heart attacks, strokes and other cardiovascular incidents can be cut by 20 to 40 per cent through use of a polypill which combines three blood pressure medications and a lipid lowering medication taken alone or with aspirin.

16 Nov 2020

Lower choline in pregnant Black American women linked to higher levels of stress hormone

Researchers at the University of Colorado Anschutz Medical Campus have found that many pregnant Black Americans have low levels of choline, an essential nutrient that aids in prenatal brain development. Stress caused by institutional racism may play a role.

16 Nov 2020

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

The fish oil-based medication known as omega-3 carboxylic acids or omega-3 CA did not decrease the risk of cardiac events compared to a placebo, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Moderna's COVID-19 vaccine nearly 95% effective

US company Moderna have just released their early phase 3 clinical trial results for their COVID-19 vaccine which is nearly 95% effective.

16 Nov 2020

Placebo News and Research

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

Sinovac Biotech's COVID-19 vaccine candidate triggers immune response

Texas Heart Institute to participate in a study to treat ARDS in hospitalized COVID-19 patients

NIH-funded study to test emergency treatment for devastating stroke in Memphis

Blood pressure drug eases recovery for alcoholics with withdrawal symptoms

UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients

Vitamin D3 supplementation shows no therapeutic benefits in severe COVID-19 patients, study finds

Investigational drug helped improve heart health in patients with chronic conditions

Combination of ticagrelor and aspirin reduces subsequent stroke risk in patients with heart plaque

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

Study: Novel drug may treat reproductive health problems in women

Researchers report encouraging results from in vitro combination therapy against COVID-19

Study shows favorable impact of medication on cardiac structure and function

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Lower choline in pregnant Black American women linked to higher levels of stress hormone

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

Moderna's COVID-19 vaccine nearly 95% effective

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News